Fred Wolfe

8.1k total citations
39 papers, 2.4k citations indexed

About

Fred Wolfe is a scholar working on Rheumatology, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Fred Wolfe has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 8 papers in Economics and Econometrics and 6 papers in Psychiatry and Mental health. Recurrent topics in Fred Wolfe's work include Rheumatoid Arthritis Research and Therapies (21 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Systemic Lupus Erythematosus Research (8 papers). Fred Wolfe is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (21 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Systemic Lupus Erythematosus Research (8 papers). Fred Wolfe collaborates with scholars based in United States, Switzerland and United Kingdom. Fred Wolfe's co-authors include Donna Hawley, Kaleb Michaud, Hawley Dj, Allan Wailoo, Winfried Häuser, D A Bloch, Beat A. Michel, J F Fries, Mónica Hernández Alava and M A Cathey and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Inflammatory Bowel Diseases.

In The Last Decade

Fred Wolfe

38 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Wolfe United States 25 1.4k 493 436 393 214 39 2.4k
M A Cathey United States 17 1.6k 1.1× 417 0.8× 528 1.2× 522 1.3× 261 1.2× 19 2.6k
C. H. Goldsmith Canada 22 850 0.6× 329 0.7× 208 0.5× 176 0.4× 395 1.8× 52 1.9k
Ahad Ashrafi‐Asgarabad Iran 13 1.2k 0.8× 745 1.5× 200 0.5× 208 0.5× 181 0.8× 16 2.7k
James Witter United States 21 1.4k 1.0× 243 0.5× 157 0.4× 211 0.5× 427 2.0× 29 3.2k
Paresh Jobanputra United Kingdom 25 1.4k 1.0× 274 0.6× 85 0.2× 446 1.1× 404 1.9× 54 2.6k
Hatice Bodur Türkiye 26 940 0.7× 192 0.4× 163 0.4× 309 0.8× 312 1.5× 129 2.1k
D. van der Heijde Netherlands 22 2.7k 1.9× 403 0.8× 212 0.5× 828 2.1× 555 2.6× 36 3.2k
Pınar Borman Türkiye 24 537 0.4× 228 0.5× 239 0.5× 174 0.4× 156 0.7× 109 1.7k
J. W. J. Bijlsma Netherlands 27 1.7k 1.2× 461 0.9× 125 0.3× 229 0.6× 263 1.2× 57 2.6k
Barry E. Koehler Canada 11 940 0.7× 249 0.5× 286 0.7× 74 0.2× 588 2.7× 20 1.6k

Countries citing papers authored by Fred Wolfe

Since Specialization
Citations

This map shows the geographic impact of Fred Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Wolfe more than expected).

Fields of papers citing papers by Fred Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Wolfe. The network helps show where Fred Wolfe may publish in the future.

Co-authorship network of co-authors of Fred Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Wolfe. A scholar is included among the top collaborators of Fred Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Wolfe. Fred Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fors, Egil A., Knut‐Arne Wensaas, Hilde Eide, et al.. (2020). Fibromyalgia 2016 criteria and assessments: comprehensive validation in a Norwegian population. Scandinavian Journal of Pain. 20(4). 663–672. 20 indexed citations
2.
Alava, Mónica Hernández, Allan Wailoo, Fred Wolfe, & Kaleb Michaud. (2013). The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Lara D. Veeken. 52(5). 944–950. 60 indexed citations
3.
Langhorst, Jost, et al.. (2013). Short-Term Stress, but Not Mucosal Healing Nor Depression Was Predictive for the Risk of Relapse in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 19(11). 2380–2386. 70 indexed citations
4.
Fitzcharles, Mary‐Ann, Peter A. Ste‐Marie, Pantelis Panopalis, et al.. (2012). The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort. BMC Musculoskeletal Disorders. 13(1). 179–179. 40 indexed citations
5.
Michaud, Kaleb, et al.. (2012). Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 22(3). 238–244. 94 indexed citations
6.
Courvoisier, Delphine S., Thomas Agoritsas, Kaleb Michaud, et al.. (2011). Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis. Arthritis Care & Research. 64(2). 190–196. 36 indexed citations
7.
Finckh, Axel, et al.. (2010). Patient repositioning reproducibility of joint space width measurements on hand radiographs. Arthritis Care & Research. 63(2). 203–207. 16 indexed citations
8.
Curtis, Jeffrey R., Archana Jain, Johan Askling, et al.. (2010). A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries. Seminars in Arthritis and Rheumatism. 40(1). 2–14.e1. 147 indexed citations
9.
Sawitzke, Allen D., Dorothy D. Dunlop, Crystal L. Harris, et al.. (2010). Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Annals of the Rheumatic Diseases. 69(8). 1459–1464. 171 indexed citations
10.
Wolfe, Fred. (2009). Fibromyalgia Wars – II Dr. Wolfe replies. The Journal of Rheumatology. 36(12). 2840–2840. 2 indexed citations
11.
Kavanaugh, Arthur, et al.. (2008). High unmet need for arthritis pain management among EU and US rheumatoid arthritis patients despite effective therapies. Arthritis & Rheumatism. 58.
12.
Sawitzke, Allen D., Helen Shi, Dorothy D. Dunlop, et al.. (2008). The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial. Arthritis & Rheumatism. 58(10). 3183–3191. 178 indexed citations
13.
Wailoo, Allan, Nick Bansback, Alan Brennan, et al.. (2008). Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis. Arthritis & Rheumatism. 58(4). 939–946. 71 indexed citations
14.
Wolfe, Fred & Johannes J. Rasker. (2006). The Symptom Intensity Scale, fibromyalgia and the meaning of fibromyalgia like symptoms. University of Twente Research Information. 33. 2113–2114. 1 indexed citations
15.
Wolfe, Fred & Donna Hawley. (1998). The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.. PubMed. 25(11). 2108–17. 327 indexed citations
16.
Williams, Catherine A., D. Blöch, John Sibley, et al.. (1996). Lymphoma and Luekemia in Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 2(2). 64–72. 20 indexed citations
17.
Wolfe, Fred. (1990). 50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis.. PubMed. 22. 24–32. 50 indexed citations
18.
Wolfe, Fred, et al.. (1988). Prevalence of Familial Occurrence in Patients with Rheumatoid Arthritis. Lara D. Veeken. XXVII(suppl 2). 150–152. 29 indexed citations
19.
Wolfe, Fred, et al.. (1986). A controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome.. PubMed. 13(6). 1086–92. 17 indexed citations
20.
Wolfe, Fred, et al.. (1984). Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis.. PubMed. 11(4). 500–6. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M A Cathey Breakdown of academic impact, for papers by C. H. Goldsmith Breakdown of academic impact, for papers by Ahad Ashrafi‐Asgarabad Breakdown of academic impact, for papers by James Witter Breakdown of academic impact, for papers by Paresh Jobanputra Breakdown of academic impact, for papers by Hatice Bodur Breakdown of academic impact, for papers by D. van der Heijde Breakdown of academic impact, for papers by Pınar Borman Breakdown of academic impact, for papers by J. W. J. Bijlsma Breakdown of academic impact, for papers by Barry E. Koehler
Rankless by CCL
2026